Cargando…
Spinal cannabinoid receptor 2 activation reduces hypersensitivity associated with bone cancer pain and improves the integrity of the blood–spinal cord barrier
BACKGROUND: Disruption of the blood–spinal cord barrier (BSCB) can facilitate inflammation that results in pain hypersensitivity. Proinflammatory cytokines produced by activated microglia and astrocytes damage the BSCB. This study aims to explore whether the BSCB is damaged in the bone cancer pain (...
Autores principales: | Wang, Chenchen, Xu, Ke, Wang, Yu, Mao, Yanting, Huang, Yulin, Liang, Ying, Liu, Yue, Hao, Jing, Gu, Xiaoping, Ma, Zhengliang, Sun, Yu'e |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513263/ https://www.ncbi.nlm.nih.gov/pubmed/32796132 http://dx.doi.org/10.1136/rapm-2019-101262 |
Ejemplares similares
-
Cannabinoid receptor 2-selective agonist JWH015 attenuates bone cancer pain through the amelioration of impaired autophagy flux induced by inflammatory mediators in the spinal cord
por: Mao, Yanting, et al.
Publicado: (2019) -
Pioglitazone Attenuates Experimental Colitis-Associated Hyperalgesia through Improving the Intestinal Barrier Dysfunction
por: Huang, Yulin, et al.
Publicado: (2020) -
CREB-regulated transcription coactivator 1 enhances CREB-dependent gene expression in spinal cord to maintain the bone cancer pain in mice
por: Liang, Ying, et al.
Publicado: (2016) -
Preoperative anxiety-induced glucocorticoid signaling reduces
GABAergic markers in spinal cord and promotes postoperative hyperalgesia by
affecting neuronal PAS domain protein 4
por: Wu, Hao, et al.
Publicado: (2019) -
Dehydrocorydaline attenuates bone cancer pain by shifting microglial M1/M2 polarization toward the M2 phenotype
por: Huo, Wenwen, et al.
Publicado: (2018)